EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
EyePoint Pharmaceuticals missed estimated earnings by 11.32%, reporting an EPS of $-0.59 versus an estimate of $-0.53.
Revenue was up $4.41 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.18 which was followed by a 7.4% increase in the share price the next day.
Here's a look at EyePoint Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.40 | -0.43 | -0.46 | -0.17 |
| EPS Actual | -0.58 | -0.42 | -0.50 | -1 |
| Revenue Estimate | 9.84M | 9.13M | 7.93M | 20.44M |
| Revenue Actual | 9.06M | 9.01M | 7.32M | 7.13M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
